Skip to product information
1 of 3

BIOTONE® EASE-Z Diabetics' Dry Skin Therapy Foot Cream

BIOTONE® EASE-Z Diabetics' Dry Skin Therapy Foot Cream

Read reviews →
Also see: Amazon · Google · Reddit
Regular price $15.49 USD
Regular price Sale price $15.49 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

The full picture

Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

45/100
Rejected

Six-dimension breakdown

Transparency
52

Why this scored 45/100

BIOTONE's EASE-Z Diabetics' Dry Skin Therapy Foot Cream is a competently formulated diabetic-specific foot care product (zinc-based barrier, shea butter and lecithin moisturizing components) marketed to a legitimate clinical need: diabetic peripheral neuropathy and diabetic-foot skin breakdown are well-established complications requiring dedicated skincare. The product is honest about its indication and BIOTONE is a real brand. The issue for a Vyvata listing is scope: this is a condition-specific medical skincare product for diabetics, not a biohacking-optimization or general-wellness recovery product. Vyvata's platform is for consumers making choices about performance, recovery, sleep, diagnostics, and cognitive-supplement products — not for medical-management adjuncts for chronic conditions like diabetes. The category taxonomy has no clean home for diabetic-foot skincare, and the buyer motivation is disease management rather than wellness optimization. Placed under compression_therapy only because there is no better subcategory fit. Rejected as out_of_scope_for_biohacking — not because the product is harmful or dishonest, but because the platform is not the correct channel. Diabetic-foot skincare belongs in a medical-retail or pharmacy channel with clinician guidance. Would become listable at Standard 55+ only if repositioned as general-population dry-foot skincare (dropping the diabetic-specific indication and the medical-adjacent claims).

Last scored: Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

  • 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
  • 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
  • 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
  • 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
  • 0–19: No credible evidence base or unverifiable claims.

FAQ data has not been generated for this product yet. See the site FAQ for general questions.

Customer reviews

Reviews on other platforms

The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score
45 / 100
Tier
Rejected
Category
Recovery regeneration
Subcategory
compression therapy
Last scored
Third-party certifications
None on record at time of scoring
Vendor
Orthopedic Outfitters
Product type
Gel, Lotion & Cream
Tags
Orthopedic Outfitters, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.

View full details